Mark Burns, PhD, assistant professor of neuroscience, is an expert in the biochemical link between traumatic brain injury (TBI) and other brain disorders such as Alzheimer’s disease. In stroke and TBI, brain damage continues for days and weeks after the initial injury – a process known as secondary injury. Burns and his colleagues have designed a series of experiments to test on laboratory models of TBI a group of drugs – already government approved for other uses -- that appear to have wide spectrum, potent properties to protect the brain from this ongoing trauma and injury common to stroke and TBI. Burns earned his PhD at the National University of Ireland, Galway and performed his postdoctoral training at New York University. Well-published in high-impact journals, he is editor-in-chief of the journal Frontiers in Neurodegenerative Disorders, a editorial board-member and reviewer for several national and international biomedical journals and a standing member of the Society for Neuroscience and the National Neurotrauma Association.
Protecting Our Brains from Ongoing Trauma After Injury
Principal Investigators: Juan M. Saavedra, MD, Mark Burns, PhD